Login to Your Account



Ignyta's Combo Drug/Diagnostics Strategy a Differentiator

By Marie Powers
Staff Writer

Friday, July 19, 2013
A small biotech buy earlier this year could someday reap big rewards for Ignyta Inc., a San Diego firm that is integrating targeted drug discovery and development with companion diagnostics for patient stratification.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription